시장조사 보고서 : 세계의 입술 포진용 치료약 시장예측 2021년-2026년

■ 영문 제목 : Global Herpes Labialis Drugs Market Growth 2021-2026
	■ 상품코드 : LPI-2108K200023 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 167 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 입술 포진용 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (발라시클로비르, 아키클로비르, 팜치클로비르, 도코사놀, 기타)와 용도별 시장규모 (외용, 경구, 주사) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 입술 포진용 치료약 시장 점유율
- 지역별 입술 포진용 치료약 시장규모
- 주요지역의 종류별 시장규모 (발라시클로비르, 아키클로비르, 팜치클로비르, 도코사놀, 기타)
- 주요지역의 용도별 시장규모 (외용, 경구, 주사)
- 미주의 입술 포진용 치료약 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 입술 포진용 치료약 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 입술 포진용 치료약 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 입술 포진용 치료약 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 입술 포진용 치료약 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2020 growth of Herpes Labialis Drugs will have significant change from previous year. By the most conservative estimates of global Herpes Labialis Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Herpes Labialis Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Labialis Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Valacyclovir
Aciclovir
Famciclovir
Docosanol
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
External Use
Oral
Injection

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Herpes Labialis Drugs Consumption 2016-2026
2.1.2 Herpes Labialis Drugs Consumption CAGR by Region
2.2 Herpes Labialis Drugs Segment by Type
2.2.1 Valacyclovir
2.2.2 Aciclovir
2.2.3 Famciclovir
2.2.4 Docosanol
2.2.5 Other
2.3 Herpes Labialis Drugs Sales by Type
2.3.1 Global Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Herpes Labialis Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Herpes Labialis Drugs Sale Price by Type (2016-2021)
2.4 Herpes Labialis Drugs Segment by Application
2.4.1 External Use
2.4.2 Oral
2.4.3 Injection
2.5 Herpes Labialis Drugs Sales by Application
2.5.1 Global Herpes Labialis Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Herpes Labialis Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Herpes Labialis Drugs Sale Price by Application (2016-2021)

3 Global Herpes Labialis Drugs by Company
3.1 Global Herpes Labialis Drugs Sales Market Share by Company
3.1.1 Global Herpes Labialis Drugs Sales by Company (2019-2021)
3.1.2 Global Herpes Labialis Drugs Sales Market Share by Company (2019-2021)
3.2 Global Herpes Labialis Drugs Revenue Market Share by Company
3.2.1 Global Herpes Labialis Drugs Revenue by Company (2019-2021)
3.2.2 Global Herpes Labialis Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Herpes Labialis Drugs Sale Price by Company
3.4 Global Manufacturers Herpes Labialis Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Herpes Labialis Drugs Product Location Distribution
3.4.2 Players Herpes Labialis Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Herpes Labialis Drugs by Region
4.1 Global Herpes Labialis Drugs by Region
4.1.1 Global Herpes Labialis Drugs Sales by Region
4.1.2 Global Herpes Labialis Drugs Revenue by Region
4.2 Americas Herpes Labialis Drugs Sales Growth
4.3 APAC Herpes Labialis Drugs Sales Growth
4.4 Europe Herpes Labialis Drugs Sales Growth
4.5 Middle East & Africa Herpes Labialis Drugs Sales Growth

5 Americas
5.1 Americas Herpes Labialis Drugs Sales by Country
5.1.1 Americas Herpes Labialis Drugs Sales by Country (2016-2021)
5.1.2 Americas Herpes Labialis Drugs Revenue by Country (2016-2021)
5.2 Americas Herpes Labialis Drugs Sales by Type
5.3 Americas Herpes Labialis Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Herpes Labialis Drugs Sales by Region
6.1.1 APAC Herpes Labialis Drugs Sales by Region (2016-2021)
6.1.2 APAC Herpes Labialis Drugs Revenue by Region (2016-2021)
6.2 APAC Herpes Labialis Drugs Sales by Type
6.3 APAC Herpes Labialis Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Herpes Labialis Drugs by Country
7.1.1 Europe Herpes Labialis Drugs Sales by Country (2016-2021)
7.1.2 Europe Herpes Labialis Drugs Revenue by Country (2016-2021)
7.2 Europe Herpes Labialis Drugs Sales by Type
7.3 Europe Herpes Labialis Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Herpes Labialis Drugs by Country
8.1.1 Middle East & Africa Herpes Labialis Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Herpes Labialis Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Herpes Labialis Drugs Sales by Type
8.3 Middle East & Africa Herpes Labialis Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Herpes Labialis Drugs Distributors
10.3 Herpes Labialis Drugs Customer

11 Global Herpes Labialis Drugs Market Forecast
11.1 Global Herpes Labialis Drugs Forecast by Region
11.1.1 Global Herpes Labialis Drugs Forecast by Regions (2021-2026)
11.2.2 Global Herpes Labialis Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Herpes Labialis Drugs Forecast by Type
11.7 Global Herpes Labialis Drugs Forecast by Application

12 Key Players Analysis
12.1 GSK
12.1.1 GSK GSK Company Information
12.1.2 GSK Herpes Labialis Drugs Product Offered
12.1.3 GSK Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 GSK Main Business Overview
12.1.5 GSK Latest Developments
12.2 Novartis
12.2.1 Novartis Company Information
12.2.2 Novartis Herpes Labialis Drugs Product Offered
12.2.3 Novartis Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novartis Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Teva
12.3.1 Teva Company Information
12.3.2 Teva Herpes Labialis Drugs Product Offered
12.3.3 Teva Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Teva Main Business Overview
12.3.5 Teva Latest Developments
12.4 Mylan
12.4.1 Mylan Company Information
12.4.2 Mylan Herpes Labialis Drugs Product Offered
12.4.3 Mylan Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Mylan Main Business Overview
12.4.5 Mylan Latest Developments
12.5 Cadila
12.5.1 Cadila Company Information
12.5.2 Cadila Herpes Labialis Drugs Product Offered
12.5.3 Cadila Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Cadila Main Business Overview
12.5.5 Cadila Latest Developments
12.6 Apotex
12.6.1 Apotex Company Information
12.6.2 Apotex Herpes Labialis Drugs Product Offered
12.6.3 Apotex Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Apotex Main Business Overview
12.6.5 Apotex Latest Developments
12.7 Daewoong Pharmaceutical
12.7.1 Daewoong Pharmaceutical Company Information
12.7.2 Daewoong Pharmaceutical Herpes Labialis Drugs Product Offered
12.7.3 Daewoong Pharmaceutical Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Daewoong Pharmaceutical Main Business Overview
12.7.5 Daewoong Pharmaceutical Latest Developments
12.8 Livzon
12.8.1 Livzon Company Information
12.8.2 Livzon Herpes Labialis Drugs Product Offered
12.8.3 Livzon Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Livzon Main Business Overview
12.8.5 Livzon Latest Developments
12.9 Luoxin
12.9.1 Luoxin Company Information
12.9.2 Luoxin Herpes Labialis Drugs Product Offered
12.9.3 Luoxin Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Luoxin Main Business Overview
12.9.5 Luoxin Latest Developments
12.10 Med shine
12.10.1 Med shine Company Information
12.10.2 Med shine Herpes Labialis Drugs Product Offered
12.10.3 Med shine Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Med shine Main Business Overview
12.10.5 Med shine Latest Developments
12.11 Bayer (Campho Phenique)
12.11.1 Bayer (Campho Phenique) Company Information
12.11.2 Bayer (Campho Phenique) Herpes Labialis Drugs Product Offered
12.11.3 Bayer (Campho Phenique) Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Bayer (Campho Phenique) Main Business Overview
12.11.5 Bayer (Campho Phenique) Latest Developments
12.12 Blistex
12.12.1 Blistex Company Information
12.12.2 Blistex Herpes Labialis Drugs Product Offered
12.12.3 Blistex Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Blistex Main Business Overview
12.12.5 Blistex Latest Developments
12.13 Kelun Group
12.13.1 Kelun Group Company Information
12.13.2 Kelun Group Herpes Labialis Drugs Product Offered
12.13.3 Kelun Group Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Kelun Group Main Business Overview
12.13.5 Kelun Group Latest Developments
12.14 Hikma
12.14.1 Hikma Company Information
12.14.2 Hikma Herpes Labialis Drugs Product Offered
12.14.3 Hikma Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Hikma Main Business Overview
12.14.5 Hikma Latest Developments
12.15 Haiwang
12.15.1 Haiwang Company Information
12.15.2 Haiwang Herpes Labialis Drugs Product Offered
12.15.3 Haiwang Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Haiwang Main Business Overview
12.15.5 Haiwang Latest Developments
12.16 Carmex
12.16.1 Carmex Company Information
12.16.2 Carmex Herpes Labialis Drugs Product Offered
12.16.3 Carmex Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Carmex Main Business Overview
12.16.5 Carmex Latest Developments
12.17 Cipher
12.17.1 Cipher Company Information
12.17.2 Cipher Herpes Labialis Drugs Product Offered
12.17.3 Cipher Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Cipher Main Business Overview
12.17.5 Cipher Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Herpes Labialis Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Valacyclovir
Table 3. Major Players of Aciclovir
Table 4. Major Players of Famciclovir
Table 5. Major Players of Docosanol
Table 6. Major Players of Other
Table 7. Global Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 8. Global Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 9. Global Herpes Labialis Drugs Revenue by Type (2016-2021) & ($ million)
Table 10. Global Herpes Labialis Drugs Revenue Market Share by Type (2016-2021)
Table 11. Global Herpes Labialis Drugs Sale Price by Type (2016-2021)
Table 12. Global Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 13. Global Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 14. Global Herpes Labialis Drugs Value by Application (2016-2021)
Table 15. Global Herpes Labialis Drugs Revenue Market Share by Application (2016-2021)
Table 16. Global Herpes Labialis Drugs Sale Price by Application (2016-2021)
Table 17. Global Herpes Labialis Drugs Sales by Company (2019-2021) & (K Pcs)
Table 18. Global Herpes Labialis Drugs Sales Market Share by Company (2019-2021)
Table 19. Global Herpes Labialis Drugs Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Herpes Labialis Drugs Revenue Market Share by Company (2019-2021)
Table 21. Global Herpes Labialis Drugs Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Herpes Labialis Drugs Producing Area Distribution and Sales Area
Table 23. Players Herpes Labialis Drugs Products Offered
Table 24. Herpes Labialis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Herpes Labialis Drugs Sales by Region (2016-2021) (K Pcs)
Table 28. Global Herpes Labialis Drugs Sales Market Share by Region (2016-2021)
Table 29. Global Herpes Labialis Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Herpes Labialis Drugs Revenue Market Share by Region (2016-2021)
Table 31. Americas Herpes Labialis Drugs Sales by Country (2016-2021) & (K Pcs)
Table 32. Americas Herpes Labialis Drugs Sales Market Share by Country (2016-2021)
Table 33. Americas Herpes Labialis Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Herpes Labialis Drugs Revenue Market Share by Country (2016-2021)
Table 35. Americas Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 36. Americas Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 37. Americas Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 38. Americas Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 39. APAC Herpes Labialis Drugs Sales by Region (2016-2021) & (K Pcs)
Table 40. APAC Herpes Labialis Drugs Sales Market Share by Region (2016-2021)
Table 41. APAC Herpes Labialis Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Herpes Labialis Drugs Revenue Market Share by Region (2016-2021)
Table 43. APAC Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 44. APAC Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 45. APAC Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 46. APAC Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 47. Europe Herpes Labialis Drugs Sales by Country (2016-2021) & (K Pcs)
Table 48. Europe Herpes Labialis Drugs Sales Market Share by Country (2016-2021)
Table 49. Europe Herpes Labialis Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Herpes Labialis Drugs Revenue Market Share by Country (2016-2021)
Table 51. Europe Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 52. Europe Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 53. Europe Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 54. Europe Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Herpes Labialis Drugs Sales by Country (2016-2021) & (K Pcs)
Table 56. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Herpes Labialis Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Herpes Labialis Drugs Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 60. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 62. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 63. Global Herpes Labialis Drugs Sales Forecast by Type (2021-2026) & (K Pcs)
Table 64. Global Herpes Labialis Drugs Sales Market Share Forecast by Type (2021-2026)
Table 65. Global Herpes Labialis Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 66. Global Herpes Labialis Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 67. Global Herpes Labialis Drugs Sales Forecast by Application (2021-2026) & (K Pcs)
Table 68. Global Herpes Labialis Drugs Sales Market Share Forecast by Application (2021-2026)
Table 69. Global Herpes Labialis Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 70. Global Herpes Labialis Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 71. GSK Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 72. GSK Herpes Labialis Drugs Product Offered
Table 73. GSK Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 74. GSK Main Business
Table 75. GSK Latest Developments
Table 76. Novartis Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 77. Novartis Herpes Labialis Drugs Product Offered
Table 78. Novartis Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. Teva Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. Teva Herpes Labialis Drugs Product Offered
Table 83. Teva Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 84. Teva Main Business
Table 85. Teva Latest Developments
Table 86. Mylan Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Mylan Herpes Labialis Drugs Product Offered
Table 88. Mylan Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 89. Mylan Main Business
Table 90. Mylan Latest Developments
Table 91. Cadila Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Cadila Herpes Labialis Drugs Product Offered
Table 93. Cadila Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 94. Cadila Main Business
Table 95. Cadila Latest Developments
Table 96. Apotex Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Apotex Herpes Labialis Drugs Product Offered
Table 98. Apotex Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 99. Apotex Main Business
Table 100. Apotex Latest Developments
Table 101. Daewoong Pharmaceutical Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Daewoong Pharmaceutical Herpes Labialis Drugs Product Offered
Table 103. Daewoong Pharmaceutical Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 104. Daewoong Pharmaceutical Main Business
Table 105. Daewoong Pharmaceutical Latest Developments
Table 106. Livzon Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Livzon Herpes Labialis Drugs Product Offered
Table 108. Livzon Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 109. Livzon Main Business
Table 110. Livzon Latest Developments
Table 111. Luoxin Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Luoxin Herpes Labialis Drugs Product Offered
Table 113. Luoxin Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 114. Luoxin Main Business
Table 115. Luoxin Latest Developments
Table 116. Med shine Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Med shine Herpes Labialis Drugs Product Offered
Table 118. Med shine Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 119. Med shine Main Business
Table 120. Med shine Latest Developments
Table 121. Bayer (Campho Phenique) Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Bayer (Campho Phenique) Herpes Labialis Drugs Product Offered
Table 123. Bayer (Campho Phenique) Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 124. Bayer (Campho Phenique) Main Business
Table 125. Bayer (Campho Phenique) Latest Developments
Table 126. Blistex Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Blistex Herpes Labialis Drugs Product Offered
Table 128. Blistex Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 129. Blistex Main Business
Table 130. Blistex Latest Developments
Table 131. Kelun Group Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Kelun Group Herpes Labialis Drugs Product Offered
Table 133. Kelun Group Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 134. Kelun Group Main Business
Table 135. Kelun Group Latest Developments
Table 136. Hikma Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. Hikma Herpes Labialis Drugs Product Offered
Table 138. Hikma Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 139. Hikma Main Business
Table 140. Hikma Latest Developments
Table 141. Haiwang Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Haiwang Herpes Labialis Drugs Product Offered
Table 143. Haiwang Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 144. Haiwang Main Business
Table 145. Haiwang Latest Developments
Table 146. Carmex Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. Carmex Herpes Labialis Drugs Product Offered
Table 148. Carmex Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 149. Carmex Main Business
Table 150. Carmex Latest Developments
Table 151. Cipher Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 152. Cipher Herpes Labialis Drugs Product Offered
Table 153. Cipher Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 154. Cipher Main Business
Table 155. Cipher Latest Developments
List of Figures
Figure 1. Picture of Herpes Labialis Drugs
Figure 2. Herpes Labialis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Herpes Labialis Drugs Sales Growth Rate 2016-2026 (K Pcs)
Figure 7. Global Herpes Labialis Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Herpes Labialis Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Valacyclovir
Figure 10. Product Picture of Aciclovir
Figure 11. Product Picture of Famciclovir
Figure 12. Product Picture of Docosanol
Figure 13. Product Picture of Other
Figure 14. Global Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 15. Global Herpes Labialis Drugs Revenue Market Share by Type (2016-2021)
Figure 16. Herpes Labialis Drugs Consumed in External Use
Figure 17. Global Herpes Labialis Drugs Market: External Use (2016-2021) & (K Pcs)
Figure 18. Herpes Labialis Drugs Consumed in Oral
Figure 19. Global Herpes Labialis Drugs Market: Oral (2016-2021) & (K Pcs)
Figure 20. Herpes Labialis Drugs Consumed in Injection
Figure 21. Global Herpes Labialis Drugs Market: Injection (2016-2021) & (K Pcs)
Figure 22. Global Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Figure 23. Global Herpes Labialis Drugs Revenue Market Share by Application in 2020
Figure 24. Global Herpes Labialis Drugs Revenue Market by Company in 2020 ($ Million)
Figure 25. Global Herpes Labialis Drugs Revenue Market Share by Company in 2020
Figure 26. Global Herpes Labialis Drugs Sales Market Share by Regions (2016-2021)
Figure 27. Global Herpes Labialis Drugs Revenue Market Share by Region in 2020
Figure 28. Americas Herpes Labialis Drugs Sales 2016-2021 (K Pcs)
Figure 29. Americas Herpes Labialis Drugs Revenue 2016-2021 ($ Millions)
Figure 30. APAC Herpes Labialis Drugs Sales 2016-2021 (K Pcs)
Figure 31. APAC Herpes Labialis Drugs Revenue 2016-2021 ($ Millions)
Figure 32. Europe Herpes Labialis Drugs Sales 2016-2021 (K Pcs)
Figure 33. Europe Herpes Labialis Drugs Revenue 2016-2021 ($ Millions)
Figure 34. Middle East & Africa Herpes Labialis Drugs Sales 2016-2021 (K Pcs)
Figure 35. Middle East & Africa Herpes Labialis Drugs Revenue 2016-2021 ($ Millions)
Figure 36. Americas Herpes Labialis Drugs Sales Market Share by Country in 2020
Figure 37. Americas Herpes Labialis Drugs Revenue Market Share by Country in 2020
Figure 38. Americas Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 39. Americas Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 40. United States Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 41. Canada Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 42. Mexico Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 43. Brazil Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. APAC Herpes Labialis Drugs Sales Market Share by Region in 2020
Figure 45. APAC Herpes Labialis Drugs Revenue Market Share by Regions in 2020
Figure 46. APAC Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 47. APAC Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 48. China Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Japan Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Korea Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Southeast Asia Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. India Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Australia Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Europe Herpes Labialis Drugs Sales Market Share by Country in 2020
Figure 55. Europe Herpes Labialis Drugs Revenue Market Share by Country in 2020
Figure 56. Europe Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 57. Europe Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 58. Germany Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. France Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. UK Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. Italy Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. Russia Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Country in 2020
Figure 64. Middle East & Africa Herpes Labialis Drugs Revenue Market Share by Country in 2020
Figure 65. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 66. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 67. Egypt Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. South Africa Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Israel Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. Turkey Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. GCC Country Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles

※본 조사보고서 [세계의 입술 포진용 치료약 시장예측 2021년-2026년] (코드 : LPI-2108K200023) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 입술 포진용 치료약 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 당뇨병 치료약 시장예측 2021년-2026년
LPI-2108K202104 / LP Information / 2021년 8월 / 본 조사보고서는 당뇨병 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Antidiabetic Drugs will have significant change from previous year. By the most conservative estimates of global Antidiabetic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 정신 장애 치료약 시장예측 2021년-2026년
LPI-2108K201578 / LP Information / 2021년 8월 / 본 조사보고서는 정신 장애 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Mental Disorders Drugs will have significant change from previous year. By the most conservative estimates of global Mental Disorders Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 양극성 장애 약물 시장예측 2021년-2026년
LPI-2108K202119 / LP Information / 2021년 8월 / 본 조사보고서는 양극성 장애 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Bipolar Disorder Drugs will have significant change from previous year. By the most conservative estimates of global Bipolar Disorder Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 항우울제 시장예측 2021년-2026년
LPI-2108K202103 / LP Information / 2021년 8월 / 본 조사보고서는 항우울제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Antidepressant Drugs will have significant change from previous year. By the most conservative estimates of global Antidepressant Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 12180 million in 2019. Over...

세계의 생물학적 치료제 시장예측 2021년-2026년
LPI-2108K202118 / LP Information / 2021년 8월 / 본 조사보고서는 생물학적 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Biologic Therapeutics Drugs will have significant change from previous year. By the most conservative estimates of global Biologic Therapeutics Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 315410 million in...

세계의 고지혈증 처방약 시장예측 2021년-2026년
LPI-2108K201466 / LP Information / 2021년 8월 / 본 조사보고서는 고지혈증 처방약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Hyperlipidemia Prescription Drugs will have significant change from previous year. By the most conservative estimates of global Hyperlipidemia Prescription Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 감량 치료제 시장예측 2021년-2026년
LPI-2108K200004 / LP Information / 2021년 8월 / 본 조사보고서는 감량 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Weight Loss Drugs will have significant change from previous year. By the most conservative estimates of global Weight Loss Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 동물용 통증 관리약 시장예측 2021년-2026년
LPI-2108K201967 / LP Information / 2021년 8월 / 본 조사보고서는 동물용 통증 관리약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Veterinary Pain Management Drugs will have significant change from previous year. By the most conservative estimates of global Veterinary Pain Management Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 항비만약 시장예측 2021년-2026년
LPI-2108K200019 / LP Information / 2021년 8월 / 본 조사보고서는 항비만약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Anti Obesity Drugs will have significant change from previous year. By the most conservative estimates of global Anti Obesity Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 항소화성 궤양 치료약 시장예측 2021년-2026년
LPI-2108K201064 / LP Information / 2021년 8월 / 본 조사보고서는 항소화성 궤양 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...